Review of thrombophilic states

Clinical Pediatrics

Volumn 44, Issue 3, 2005, Pages 193-199

  Beck, Michael J ^a,b,c   Berman, Brian ^a,c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ACTIVATED PROTEIN C; ANTITHROMBIN; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; LIPOPROTEIN; LOW MOLECULAR WEIGHT HEPARIN; PROTEIN C; PROTEIN S; PROTHROMBIN; THROMBIN; WARFARIN;

ANTIPHOSPHOLIPID SYNDROME; CARDIOVASCULAR DISEASE; CENTRAL VENOUS CATHETER; DIABETES MELLITUS; DRUG EFFICACY; DRUG SAFETY; ESTROGEN THERAPY; GENETIC SUSCEPTIBILITY; HUMAN; IMMOBILIZATION; INFECTION; INFLAMMATORY DISEASE; LABORATORY TEST; MASS SCREENING; NOTE; PARENTERAL NUTRITION; PREGNANCY; RISK FACTOR; SICKLE CELL ANEMIA; THROMBOPHILIA; THROMBOSIS;

ADOLESCENT; ADULT; CARRIER STATE; CHILD; HUMANS; INCIDENCE; INFANT, NEWBORN; MIDDLE AGED; THROMBOPHILIA; THROMBOSIS;

EID: 17444388456     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/000992280504400302     Document Type: Note

References (32)

1. Virchow R. Gesammalte Abhandlungen zur wissenschaftlichen Medtzin. Medinger Sohn. 1856:219-732.
2. Federman DG, Kirsner RS. An update on hypercoagulable disorders. Arch Intern Med. 2001;161:1051-1056.
3. Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med. 2001;344:1222-1231.
4. Andrew M, David M, Adams M, et al. Venous thromboembolic complications (VTE) in children: First analyses of the Canadian Registry of VTE. Blood. 1994;83:1251-1257.
5. De Stefano V, Finazzi G, Mannucci PM. Inherited thrombophilia: Pathogenesis, clinical syndromes, and management. Blood. 1996;87:3531-3544. Genetic susceptibility to venous thrombosis. N Engl J Med. 2001;344:1222-1231.
6. De Stefano V, Finazzi G, Mannucci PM. Inherited thrombophilia: Pathogenesis, clinical syndromes, and management. Blood. 1996;87:3531-3544. Genetic susceptibility to venous thrombosis. N Engl J Med. 2001;344:1222-1231.
7. Miller R, Kodish E. Causes of thrombosis. Contemp Pediatr. 1996;13:79-97.
8. Nowak-Gottl U, von Kries R, Gobel U. Neonatal symptomatic thromboembolism in Germany: Two-year survey. Arch Dis Child Fetal Neonatal Ed. 1997;76:F163-167.
9. Schmidt B, Andrew M. Neonatal thrombosis: Report of a prospective Canadian and international registry. Pediatrics. 1995;96(5 Pt 1):939-943.
10. van Ommen CH, Heijboer H, Buller HR, et al. Venous thromboembolism in childhood: A prospective two-year registry in The Netherlands. J Pediatr. 2001;139:676-681.
11. Andrew M, Paes B, Johnston M. Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol. 1990;12:95-104.
12. Wenstrom K, ed. Danforth's Obstetrics and Gynecology, ed 8. Philadelphia: Lippincott, Williams Wilkins; 1999:340.
13. Crowther MA, Kelton JG. Congenital thrombophilic states associated with venous thrombosis: A qualitative overview and proposed classification system. Ann Intern Med. 2003;138:128-134.
14. Mateo J, Oliver A, Borrell M, et al. Laboratory evaluation and clinical characteristics of 2,132 consecutive unselected patients with venous thromboembolism - results of the Spanish Multicentric Study on Thrombophilia (EMET-Study). Thromb Haemost. 1997;77:444-451.
15. Ridker PM, Hennekens CH, Miletich JP. G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men. Circulation. 1999;99:999-1004.
16. Ben-Tal O, Zivelin A, Seligsohn U. The relative frequency of hereditary thrombotic disorders among 107 patients with thrombophilia in Israel. Thromb Haemost. 1989;61:50-54.
17. Wells PS, Blajchman MA, Henderson P, et al. Prevalence of antithrombin deficiency in healthy blood donors: A cross-sectional study. Am J Hematol. 1994;45:321-324.
18. Tait RC, Walker ID, Perry DJ, et al. Prevalence of antithrombin deficiency in the healthy population. Br J Haematol. 1994;87:106-112.
19. Tait RC, Walker ID, Reitsma PH, et al. Prevalence of protein C deficiency in the healthy population. Thromb Haemost. 1995;73:87-93.
20. Sakata T, Kario K, Katayama Y, et al. Studies on congenital protein C deficiency in Japanese: prevalence, genetic analysis, and relevance to the onset of arterial occlusive diseases. Semin Thromb Hemost. 2000;26:11-16.
21. Pabinger I, Brucker S, Kyrle PA, et al. Hereditary deficiency of antithrombin III, protein C and protein S: Prevalence in patients with a history of venous thrombosis and criteria for rational patient screening. Blood Coagul Fibrinolysis. 1992;3:547-553.
22. Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb Diath Haemorrh. 1965;13:516-530.
23. 21a. Dahlback B, Hildebrand B. Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. Proc Natl Acad Sci USA. 1994;91:1396-1400.
24. Rodeghiero F, Tosetto A. Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism. Ann Intern Med. 1999;130:643-650.
25. Cattaneo M. Hyperhomocysteinemia, atherosclerosis and thrombosis. Thromb Haemost. 1999;81:165-176.
26. Ray JG. Meta-analysis of hyperhomo cysteinemia as a risk factor for venous thromboembolic disease. Arch Intern Med. 1998;158:2101-2106.
27. Kluijtmans LA, van den Heuvel LP, Boers GH, et al. Molecular genetic analysis in mild hyperhomocysteine-mia: A common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet. 1996;58:35-41.
28. Jacques PF, Bostom AG, Williams RR, et al. Relation between folate status, a common mutation in methylenete-trahydrofolate reductase, and plasma homocysteine concentrations. Circulation. 1996;93:7-9.
29. van Guldener C, Stehouwer CD. Hyperhomocysteinemia, vascular pathology, and endothelial dysfunction. Semin Thromb Hemost. 2000;26:281-289.
30. Werstuck GH, Lentz SR, Dayal S, et al. Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J Clin Invest. 2001;107:1263-1273.
31. Tormene D, Simioni P, Prandoni P, et al. The incidence of venous thromboembolism in thrombophilic children: A prospective cohort study. Blood. 2002;100:2403-2405.
32. Hatem C, Kettyle W, eds. Hematology, 12 ed. Philadelphia: ACP-ASIM; 2001:70.